Integrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumors.
Integrative genomics approaches associating DNA structure and transcriptomic analysis should allow the identification of cascades of events relating to tumor aggressiveness. While different genome alterations have been identified in pituitary tumors, none have ever been correlated with the aggressiveness. This study focused on one subtype of pituitary tumor, the prolactin (PRL) pituitary tumors, to identify molecular events associated with the aggressive and malignant phenotypes. We combined a comparative genomic hybridization and transcriptomic analysis of 13 PRL tumors classified as nonaggressive or aggressive. Allelic loss within the p arm region of chromosome 11 was detected in five of the aggressive tumors. Allelic loss in the 11q arm was observed in three of these five tumors, all three of which were considered as malignant based on the occurrence of metastases. Comparison of genomic and transcriptomic data showed that allelic loss impacted upon the expression of genes located in the imbalanced region. Data filtering allowed us to highlight five deregulated genes (DGKZ, CD44, TSG101, GTF2H1, HTATIP2), within the missing 11p region, potentially responsible for triggering the aggressive and malignant phenotypes of PRL tumors. Our combined genomic and transcriptomic analysis underlines the importance of chromosome allelic loss in determining the aggressiveness and malignancy of tumors.
INSERM, U842, Lyon, France.
Anne
A
Wierinckx
Magali
M
Roche
Gérald
G
Raverot
Catherine
C
Legras-Lachuer
Séverine
S
Croze
Nicolas
N
Nazaret
Catherine
C
Rey
Carole
C
Auger
Emmanuel
E
Jouanneau
Philippe
P
Chanson
Jacqueline
J
Trouillas
Joël
J
Lachuer
D000123:Acetyltransferases / Q000235:genetics; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002453:Cell Cycle / Q000235:genetics; D002869:Chromosome Aberrations; D002880:Chromosomes, Human, Pair 11; D055028:Comparative Genomic Hybridization; D004268:DNA-Binding Proteins / Q000235:genetics; D019852:Diacylglycerol Kinase / Q000235:genetics / Q000378:metabolism; D015536:Down-Regulation / Q000235:genetics; D056827:Endosomal Sorting Complexes Required for Transport / Q000235:genetics; D005260:Female; D020869:Gene Expression Profiling / Q000379:methods; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D018960:Hyaluronan Receptors / Q000235:genetics / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010750:Phosphoproteins / Q000235:genetics; D010911:Pituitary Neoplasms / Q000235:genetics*; D015175:Prolactinoma / Q000235:genetics*; D015398:Signal Transduction / Q000235:genetics; D051758:Transcription Factor TFIIH; D014157:Transcription Factors / Q000235:genetics; D019473:Transcription Factors, TFII / Q000235:genetics; D000099177:Tsg101 Protein
D000123:Acetyltransferases; D004268:DNA-Binding Proteins; D019852:Diacylglycerol Kinase; D056827:Endosomal Sorting Complexes Required for Transport; D018960:Hyaluronan Receptors; D010750:Phosphoproteins; D051758:Transcription Factor TFIIH; D014157:Transcription Factors; D019473:Transcription Factors, TFII; D000099177:Tsg101 Protein; C072546:GTF2H1 protein, human; C111246:HTATIP2 protein, human; C526463:DGKZ protein, human
Clin Cancer Res. 1998 Jul;4(7):1673-8
9676841
J Biol Chem. 2004 Jun 25;279(26):27781-9
15073177
J Clin Endocrinol Metab. 2010 Apr;95(4):1708-16
20164287
J Cell Biochem. 2008 Oct 15;105(3):756-65
18680142
J Neuropathol Exp Neurol. 2006 Jul;65(7):675-84
16825954
Mol Cell Biol. 2003 Jan;23(1):150-62
12482969
Cancer. 1993 Oct 15;72(8):2423-32
8402459
Oncogene. 2003 Jun 12;22(24):3742-8
12802281
Genes Chromosomes Cancer. 2000 Mar;27(3):244-51
10679913
Cancer Sci. 2010 Jan;101(1):36-45
19891661
Genes Chromosomes Cancer. 2003 Jul;37(3):225-36
12759921
Oncogene. 2010 Feb 11;29(6):865-75
19901960
Oncogene. 2006 Nov 2;25(52):6997-7008
16715129
Annu Rev Pathol. 2009;4:97-126
19400692
Endocr Relat Cancer. 2006 Sep;13(3):707-16
16954426
Mol Cell Endocrinol. 2010 Sep 15;326(1-2):71-9
20457215
Am J Pathol. 2009 May;174(5):1931-9
19349353
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1619-24
11172000
Genes Chromosomes Cancer. 2005 May;43(1):72-82
15704128
J Pathol. 1999 Jan;187(2):173-83
10365092
Hepatology. 2008 Jul;48(1):265-75
18537194
Hepatology. 2008 Mar;47(3):897-907
18176954
Leuk Lymphoma. 2000 Feb;36(5-6):463-6
10784390
Cancer Res. 1997 Jul 1;57(13):2703-9
9205080
Int J Cancer. 1996 Jan 26;65(3):301-7
8575848
Genes Chromosomes Cancer. 2007 Oct;46(10):875-94
17620294
Cancer Res. 1994 Mar 1;54(5):1331-6
8118824
BMC Syst Biol. 2010 May 17;4:67
20478067
FASEB J. 2007 Oct;21(12):3297-307
17488950
Mol Cell Endocrinol. 2010 Sep 15;326(1-2):30-9
20211685
Endocr Relat Cancer. 2007 Sep;14(3):887-900
17914117
Cancer Res. 1999 Apr 1;59(7 Suppl):1743s-1746s
10197590
Science. 1976 Oct 1;194(4260):23-8
959840
Hum Mol Genet. 1998 May;7(5):895-903
9536095
Genes Dev. 2006 Jul 1;20(13):1715-20
16818603
Eur J Endocrinol. 2007 Feb;156(2):143-53
17287403
J Clin Endocrinol Metab. 1993 Jul;77(1):50-5
8100831
Int J Cancer. 1994 Apr 15;57(2):185-91
8157356
Nat Genet. 2009 Apr;41(4):424-9
19270705
Mol Cancer. 2008 Jan 14;7:6
18194544
J Clin Endocrinol Metab. 2000 Oct;85(10):3860-5
11061550
J Clin Endocrinol Metab. 1998 Aug;83(8):2631-4
9709923
Hum Pathol. 1999 Nov;30(11):1377-82
10571521
Cell. 1996 May 3;85(3):319-29
8616888